DimoMaint is pursuing its consolidation strategy in the healthcare and biomedical sectors with a clear objective to offer organizations modern, cloud-native maintenance solutions adapted to the most demanding operational requirements. Qb7 and AssetPlus^[2] enhance the business’s health and biomedical CMMS vertical, strengthening its positioning in France.

Qb7, a French expert in the management of the maintenance of medical equipment (including scanners, dialysis machines) in hospitals and healthcare establishments, has established itself as a key player in hospital CMMS thanks to its recognized “best-in-class” platform.

AssetPlus, GE HealthCare’s long-standing CMMS solution, has been supporting biomedical teams and healthcare institutions in France and internationally for more than twenty years. With an established customer base and recognized expertise in the hospital environment, it is a strategic asset for DimoMaint in the biomedical maintenance sector.

Starting on completion of this transaction, DimoMaint will offer AssetPlus customers a gradual transition path to Qb7 and the cloud-native DimoMaint MX platform, to ensure continuity of service while providing access to next-generation technologies.
This migration will provide access to a set of operational AI features, including diagnostic assistance and intelligent document analysis.

The acquisition of Cimaint, the legacy CMMS solution, forms part of DimoMaint’s strategy to accelerate the modernization of its installed base. Developed by Quaternaire since 1989, Cimaint has a strong foothold among its customers. As part of this transaction, DimoMaint is taking over the solution’s customer portfolio and will progressively support their migration to its cloud-native platform, DimoMaint MX. This transition will enable them to benefit from broader functional coverage, continuous innovation, and an improved user experience. Carried out in close collaboration with Quaternaire, this initiative has received the full support of all customers involved.

DimoMaint is thus strengthening its presence in the healthcare sector, where the challenges of service continuity, traceability and compliance are particularly important, while expanding its customer base.

Thomas Bourgeois, CEO of DimoMaint, says: “These three simultaneous acquisitions mark a decisive step in DimoMaint’s development. With Qb7 and AssetPlus, we are significantly strengthening our presence in the healthcare sector, where the reliability of equipment is directly linked to the quality of care. With Cimaint, we are also accelerating the market migration to more efficient and future-proof cloud-native solutions. We are delighted to welcome the teams and customers of these three companies to DimoMaint.”

Joséphine Théron, Partner at Keensight Capital, added: “These transactions demonstrate DimoMaint’s ability to lead an ambitious and targeted growth strategy. The joint acquisition of Qb7 and AssetPlus is particularly strategic: it brings together a best-in-class product and an established customer base, thus building a reference hub in biomedical CMMS. We are convinced that DimoMaint has all the assets to establish itself as the European leader in this segment.”

About DimoMaint
Founded in 2009 as a subsidiary of the Dimo Software group, DimoMaint is an internationally recognized CMMS software publisher. The company has been operating as an independent group since its acquisition by Keensight Capital in 2025. It offers a comprehensive, intuitive and scalable SaaS offering that is used in more than 100 countries. DimoMaint supports manufacturers, local authorities and service companies in the continuous improvement of their maintenance processes. www.dimomaint.com

About Keensight Capital
Keensight Capital (“Keensight”), one of Europe’s leading players in the field of Growth Buyout, supports entrepreneurs in the implementation of their growth strategies. With more than 25 years of experience and more than €8bn in assets under management, Keensight Capital’s team of seasoned professionals leverages its knowledge of the investment and growth sectors to invest over the long term in profitable companies with high growth potential and revenues between €10 million and €400 million. Drawing on its expertise in the Tech and Healthcare sectors, Keensight identifies the best investment opportunities in Europe and works closely with management teams to develop and execute their strategic vision. Keensight operates in more than 90 countries around the world, with a presence in Paris, London, Boston and Singapore. www.keensight.com